BioLineRx Ltd. (BLRX) — Institutional Holders, Q2 2026
14 institutional investment managers reported a BLRX position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $207.7K. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BLRX in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- SUSQUEHANNA INTERNATIONAL GROUP, LLPNew · +30,911 sh+$96.3K
- RENAISSANCE TECHNOLOGIESNew · +15,412 sh+$48.0K
- CITADEL ADVISORSNew · +14,796 sh+$46.1K
- WELLS FARGO & COMPANYAdded · +250 sh+$779.00
- RHUMBLINE ADVISERSAdded · +125 sh+$389.00
Biggest sellers
- XTX Topco LtdSold out · -10,941 sh-$34.1K
- CITIGROUPTrimmed · -1,727 sh-$5.4K
- BNP PARIBAS FINANCIAL MARKETSTrimmed · -1,300 sh-$4.0K
- UBS Group AGTrimmed · -428 sh-$1.3K
- MORGAN STANLEYSold out · -100 sh-$312.00
BLRX 13F holders ranked 1–14 of 14
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | SUSQUEHANNA INTERNATIONAL GROUP, LLP#1 · 30,911 sh | 30,911 | $95.8K | 0.00% | New |
| 2 | RENAISSANCE TECHNOLOGIES#2 · 15,412 sh | 15,412 | $48.1K | <0.01% | New |
| 3 | CITADEL ADVISORS#3 · 14,796 sh | 14,796 | $45.9K | 0.00% | New |
| 4 | RHUMBLINE ADVISERS#4 · 2,478 sh | 2,478 | $7.7K | 0.00% | +5.3% |
| 5 | WELLS FARGO & COMPANY#5 · 2,000 sh | 2,000 | $6.2K | 0.00% | +14.3% |
| 6 | BNP PARIBAS FINANCIAL MARKETS#6 · 500 sh | 500 | $1.6K | 0.00% | -72.2% |
| 7 | Banque Cantonale Vaudoise#7 · 1 sh | 1 | $1.0K | 0.00% | 0.0% |
| 8 | Nemes Rush Group#8 · 250 sh | 250 | $780.00 | <0.01% | 0.0% |
| 9 | UBS Group AG#9 · 101 sh | 101 | $315.00 | 0.00% | -80.9% |
| 10 | NewEdge Advisors#10 · 82 sh | 82 | $256.00 | 0.00% | New |
| 11 | OSAIC#11 · 26 sh | 26 | $81.00 | 0.00% | 0.0% |
| 12 | SBI Securities , Ltd.#12 · 10 sh | 10 | $31.00 | — | New |
| 13 | DANSKE BANK A/S#13 · 2 sh | 2 | $6.00 | 0.00% | 0.0% |
| 14 | CITIGROUP#14 · 1 sh | 1 | $3.00 | 0.00% | -99.9% |
Funds that sold out of BLRX in Q2 2026 (3)
Held BLRX at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| XTX Topco Ltd10,941 sh | 10,941 | $25.3K |
| MORGAN STANLEY100 sh | 100 | $230.00 |
| Rockefeller Capital Management L.P.12 sh | 12 | $28.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.